Biogen to Sell Biosimilar-Venture Stake to Partner Samsung Biologics
Biogen Inc. is selling its share in biosimilar joint venture Samsung Bioepis for at least $2.25 billion to partner Samsung...
Biogen Inc. is selling its share in biosimilar joint venture Samsung Bioepis for at least $2.25 billion to partner Samsung...
Citigroup Inc. C -1.25% is sticking with its Covid-19 vaccine mandate for its U.S. workers. General Electric Co. GE 0.68%...
The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but...
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have...
U.S. regulators cleared use of a Covid-19 pill from Merck MRK -0.33% & Co. and partner Ridgeback Biotherapeutics LP, the...
Moderna Inc. said a third dose of its Covid-19 vaccine increased immune responses against the Omicron coronavirus variant compared with...
A federal appeals court Friday reinstated Biden administration rules that require many employers to ensure that their workers are vaccinated...
Zachary Didier took what looked like a prescription pain pill just after Christmas last year, according to his parents. It...
Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective...
Molson Coors Beverage Co. learned some lessons after bringing corporate employees back to their offices in October. Color-coded wristbands can...
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
Johnson & Johnson’s JNJ 2.55% sales climbed in the latest quarter compared with the same stretch of last year, reflecting...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
WASHINGTON—Supply-chain disruptions and global health concerns spurred the International Monetary Fund to lower its 2021 growth forecast for the world...
Johnson & Johnson’s JNJ -0.42% top scientist, who oversaw a turnaround in the company’s pharmaceutical unit and the development of...
Merck & Co. and partner Ridgeback Biotherapeutics LP said Monday they have filed an application asking U.S. health regulators to...
Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings...